tirzepatide osa fda approval GLP-1 medication is known to improve sleep apnea, but not all patients benefit equally. In a new study, presented at #ATS2026, Scott Sands, PhD, associate professor of medicine at Brigham and FDA Approves Zepbound for Moderate-to-Severe

This persistent market failure has become the single most important driver of the 503B outsourcing industrys growth and relevance

Celebrities such as Mindy Kaling have publicly shared their own weight loss journeys, inspiring others to embark on their own transformations

Weight regain occurs when incretin analogues are ceased

Until the FDA issues specific guidance defining the comparability standard for autologous C&G therapies (a process that will require substantial scientific input from industry, academia, and patient advocacy groups), the BPCIA pathway for C&G therapy biosimilars remains operationally undefined

Brand-name pharmaceuticals run $349$1,639/month